May 1, 2025 - 21:45

Democratic lawmakers in Congress are expressing strong opposition to Health Secretary Robert F. Kennedy Jr.'s recent decision to halt public comment on significant aspects of the Department of Health and Human Services (HHS) operations. This move has raised concerns among various health advocacy groups and lawmakers who believe that public input is crucial for transparency and accountability in government decision-making.
The suspension of public comment is seen as a step back from the collaborative approach that encourages citizen engagement in health policy discussions. Critics argue that the lack of public discourse could lead to decisions that do not reflect the needs and concerns of the communities served by HHS. Lawmakers are calling for a reinstatement of public comment opportunities to ensure that diverse voices are heard and considered in the policymaking process.
As the debate unfolds, the implications of this decision on public health initiatives and community trust in government remain a focal point of concern among advocates and legislators alike.
September 1, 2026 - 23:31
Medtronic invests up to $80M in medtech company Pi-Cardia with a potential buyout on the tableMedtronic is deepening its bet on structural heart technology with a new investment in Pi-Cardia, a company focused on treating calcified aortic valves. The deal could reach $80 million, and it...
September 1, 2026 - 04:37
Maryland business owner killed in pedestrian crash remembered as musician and mentorA Gaithersburg community is mourning the loss of a local business owner who was struck and killed by a vehicle earlier this week. Craig Budd Sr., known for his warmth, his guitar, and his...
August 31, 2026 - 20:23
Why Canada-US Risk Analysis Should Start With The Business ModelStandard risk analysis usually misses how deeply government decisions can hit a company`s actual worth. When looking at cross-border operations between Canada and the United States, the old...
August 31, 2026 - 10:58
Bayer's investigational PET tracer shows high accuracy for cardiac amyloidosisNew data presented at the European Society of Cardiology Congress suggests that an investigational PET imaging agent from Bayer could significantly improve the diagnosis of a debilitating heart...